Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

AstraZeneca receives positive bladder cancer trial data for Imfinzi

9th May 2025 09:29

(Alliance News) - AstraZeneca PLC on Friday said it has received positive data from a trial evaluating Imfinzi as a treatment for patients with high-risk non-muscle-invasive bladder cancer. Read More

LONDON MARKET OPEN: Fed supports dollar; UK PM to make trade update

8th May 2025 09:01

(Alliance News) - European stocks opened higher on Thursday, with the FTSE 100 registering only a minor gain, however, as investors digest Wednesday's Federal Reserve decision and look ahead to a probable Bank of England rate cut. Read More

LONDON MARKET CLOSE: FTSE 100 ends winning run ahead of Fed rate call

7th May 2025 17:01

(Alliance News) - The FTSE 100 ended a 16-day winning streak on Wednesday, ahead of interest rate decisions in the US and UK, weighed by weak pharmaceutical and telecoms stocks. Read More

LONDON MARKET MIDDAY: Stocks decline before central bank decisions

7th May 2025 12:07

(Alliance News) - Stock prices in London were weaker on Wednesday, with some pre-Federal Reserve decision nerves and geopolitical tensions hurting sentiment. Read More

AstraZeneca touts positive trial data for breast cancer treatment

7th May 2025 09:33

(Alliance News) - AstraZeneca PLC on Wednesday said it has received positive high-level results from its latest trial evaluating Enhertu in patients with high-risk, locally advanced HER2-positive early-stage breast cancer. Read More

LONDON MARKET OPEN: European shares struggle despite US-China hope

7th May 2025 08:52

(Alliance News) - London's FTSE 100 gave back a fraction of its recent progress early Wednesday, despite some optimism on the tariff front, ahead of a US interest rate decision later. Read More

AstraZeneca's Calquence gets EU approval to treat adults with MCL

6th May 2025 09:41

(Alliance News) - AstraZeneca PLC on Tuesday said Calquence plus chemoimmunotherapy has been approved in the European Union for previously untreated mantle cell lymphoma in adults. Read More

LONDON BRIEFING: AB Foods in talks with Hovis; CRH swings to loss

6th May 2025 07:54

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, kicking off the week following an extended bank holiday weekend, as Germany prepares to swear in its new chancellor and UK consumer confidence hits a new low. Read More

AstraZeneca asthma drug meets targets in phase 3 trials

2nd May 2025 10:03

(Alliance News) - AstraZeneca PLC on Friday reported that its triple-combination asthma treatment Breztri Aerosphere met all primary endpoints in two late-stage clinical trials, raising the potential to improve treatment options for patients whose condition is not controlled by current therapies. Read More

LONDON MARKET CLOSE: FTSE 100 stutters despite fresh tech-led US gains

1st May 2025 17:03

(Alliance News) - The FTSE 100 edged higher on Thursday, extending its best winning run since 2017, supported by tech-inspired gains on Wall Street. Read More

LONDON BROKER RATINGS: Deutsche Bank, Deutsche Numis raise GlobalData

1st May 2025 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET CLOSE: HSBC supports FTSE 100 as blue-chips climb again

29th Apr 2025 17:00

(Alliance News) - The FTSE 100 extended its winning run to twelve on Tuesday despite mixed earnings and more weak US economic data. Read More

LONDON MARKET MIDDAY: Stocks rise as UK grocery sales pick up

29th Apr 2025 11:52

(Alliance News) - Stock prices in London were mostly higher at midday on Tuesday, with concerns voiced following Spain and Portugal's major power cut that a similar outage could hit UK infrastructure. Read More

AstraZeneca confirms annual guidance ahead of "catalyst-rich period"

29th Apr 2025 09:29

(Alliance News) - AstraZeneca PLC on Monday said growth has continued into 2025, with the chief executive officer saying the pharmaceutical maker has "entered an unprecedented catalyst-rich period for our company". Read More

LONDON BROKER RATINGS: Berkeley and Advanced Medical Solutions raised

28th Apr 2025 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

UK earnings, trading statements calendar - next 7 days

22nd Apr 2025 16:59

Read More

Hutchmed China completes enrolment for gastric cancer drug trial

22nd Apr 2025 08:32

(Alliance News) - Hutchmed China Ltd on Tuesday said it has completed patient enrolment for a phase II registration trial of savolitinib, targeting gastric cancer in patients with MET gene amplification. Read More

LONDON MARKET CLOSE: Stocks slide in choppy trade as trade war deepens

9th Apr 2025 16:55

(Alliance News) - The FTSE 100 resumed its downward path on Wednesday, as China hit back against US tariffs, while a volatile bond market added to the nervous mood. Read More

LONDON MARKET MIDDAY: London stocks remain red as gilt yields surge

9th Apr 2025 11:57

(Alliance News) - London stocks remained in the red at midday on Wednesday, as US tariffs continue to wreak havoc on global markets, and British gilt yields reach their highest point in more than 25 years. Read More

LONDON BROKER RATINGS: Kepler raises Rolls-Royce; UBS cuts ITV

9th Apr 2025 10:08

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

12345678910
FTSE 100 Latest
Value8,554.80
Change23.19